Genomics News & Analysis | Business 2.0
- Illumina 2026: Distributed WGS MRD Kit Lands Ahead of ASCO
- Inside Illumina's 2026 Genomics Pivot — And What Rivals Are Doing
- Beyond the Sequencer: What Genomics ROI Actually Looks Like in 2026
- Why Pharma Groups Are Scaling Genomics in 2026, Led by Illumina and Roche
- Why Biotech Companies Are Accelerating Genomics Adoption in 2026, Led by Illumina, Thermo Fisher and Ginkgo
- How Genomics Is Powering Precision Care in 2026, According to Illumina, Thermo Fisher and Gartner
- Why Genomics Matters in 2026, According to Illumina and Gartner
- How Genomics Strategy Shifts in 2026, According to Illumina and Gartner
- Why Genomics Solutions Need Agentic AI in Automation Workflows
- Top 10 Genomics Startups to Watch in 2026
- Global Genomics Outlook 2026: Enterprise Adoption Accelerates
- Future of AI in Genomics Industry: Top 10 Trends in 2026
- Illumina, Roche, Thermo Fisher Lead Enterprise Genomics Adoption
- Illumina and Thermo Fisher Lead Clinical Genomics Adoption
- Illumina and Thermo Fisher Deepen Genomics Investments as Use Cases Scale
- Illumina, Thermo Fisher and 10x Genomics Strengthen Enterprise AI Deployment in 2026
- NIH Releases New Genomics Data as Illumina and CRISPR Therapeutics File Patents
- Illumina, Oxford Nanopore, Qiagen Advance Latin America Genomics With New Partnerships
- Best Genomics Conferences 2026 in London UK, Europe, US/Canada and UAE
- Bloomberg Intelligence Sees Genomics Reaching $90-120 Billion by 2030